摘要
膀胱癌是泌尿系统发病率最高的肿瘤，是多基因异常表达的结果。目前发现膀胱癌细胞总体甲基化水平比正常细胞低，但是伴有抑癌基因上游启动子区域的异常甲基化。本文就膀胱癌细胞DNA甲基化与膀胱癌关系的研究进展作一综述。
出处
《国际泌尿系统杂志》
2007年第4期462-465,共4页
International Journal of Urology and Nephrology
参考文献18
-
1Nakagawa T, Kanai Y, Ushijima S, et al. DNA hypermethylation on multiple CpG islands associated withincreased DNA methyltransferase DNMT1 protein expression during multistage urothelial carcinogenesis. J Urol,2005,173 ( 5 ) : 1767 - 1771.
-
2Catto JW, Azzouzi AR, Rehman I, et al. Promoter hypermethylation is associated with tumor location, stage, and subsequent progression in transitional cell carcinoma. J Clin Oncol, 2005,23 ( 13 ) : 2903 - 2910.
-
3Dulaimi E, Uzzo RG, Greenberg RE,et al. Detection of bladder cancer in urine by a tumor suppressor gene hypermethylation panel. Clin Cancer Res,2004,10 ( 6 ) : 1887 - 1893.
-
4Kawamoto K, Enokida H, Gotanda T,et al. p16INK4a and p14ARF methylation as a potential biomarker for human bladder cancer Biochem Biophys Res Commun ,2006,339( 3 ) :790 -796.
-
5Dominguez G,Silva J. Prevalence of aberrant methylation of p14ARF over p16INK4a in some human primary tumors Mutat Res,2003,530 (1-2):9-17.
-
6Friedrich MG, Chandrasoma S, Siegmund KD, et al. Prognostic relevance of methylation markers in patients with non - muscle invasive bladder carcinoma. Eur J Cancer,2005,41 ( 17 ) :2769 -2778.
-
7Christoph F, Weikert S, Kempkensteffen C, et al. Regularly methylated novel pro - apoptotic genes associated with recurrence in transitional cell carcinoma of the bladder. Int J Cancer,2006 : 1033 - 1041.
-
8Friedrich MG,Chandrasoma S, Siegmund KD, et al. Prognostic relevance of methylation markers in patients with non - muscle invasive bladder carcinoma . Eur J Cancer,2005,41 ( 17 ) :2769 -2778.
-
9Kawakami T, Shiina H, Igawa M, et al. Inactivation of the hMSH3 mismatch repair gene in bladder cancer. Biochem Biophys Res Commun ,2004,325 ( 3 ) :934 - 942.
-
10Kim WJ, Kim EJ, Jeong P, et al. RUNX3 inactivation by point mutations and aberrant DNA methylation in bladder tumor. Cancer Res, 2005,65 ( 20 ) :9347 - 9354.
同被引文献9
-
1汪建平,元云飞.结直肠癌DNA甲基化研究的现状[J].中华实验外科杂志,2004,21(10):1279-1280. 被引量：12
-
2张军,张旭,许凯,傅斌,郎斌,胡建庭,艾星,史涛坪,朱宏刚,陈军.膀胱移行细胞癌患者血浆p14基因异常甲基化检测的意义[J].中华实验外科杂志,2007,24(3):333-335. 被引量：6
-
3胡礼炳,王国民,张利能,查锡良.膀胱癌细胞中DAPK基因启动子甲基化状态分析[J].中华实验外科杂志,2007,24(4):489-491. 被引量：13
-
4Dulaimi E, UzzoR G, Greenberg RE, et al. Detection of bladder cancer in urine by a tumor suppressor gene hypermethylation panel. Clin Cancer Res ,2004,10 : 1887-1893.
-
5Christoph F, Kempkensteffen C, Weikert S, et al. Frequent epigenetic inactivation of p53 target genes in seminomatous and nonseminomatans germ cell tumors. Cancer Lett,2007,247:137-142.
-
6Christoph F, Weikert S, Kempkensteffen C, et al. Regularly methylated novel pro-apoptotic genes associated with recurrence in transitional cell carcinoma of the bladder. Int J Cancer,2006,119 : 1396-1402.
-
7Friedrich MG, Chandrasoma S, Siegmund KD, et al. Prognostic relevance of methylation markers in patients with non-muscle invasive bladder carcinoma. Eur J Cancer,2005,41:2769-2778.
-
8Iacopetta B, Grieu F,Li W,et al. APC gene methylation is inversely correlated with features of the CpG island methylator phenotype in colorectal cancer. Int J Cancer,2006,119:2272-2278.
-
9Pu RT, Laitala LE, Clark DP. Methylation profiling of urothelial carcinoma in bladder biopsy and urine. Acta Cyto1,2006 ,50 :499-506.
-
1房静远.DNA甲基化水平降低与消化系肿瘤[J].国外医学（消化系疾病分册）,1994,14(4):198-201. 被引量：3
-
2徐宁志,苗晶,李文梅,武纯净,邓国仁.人胃癌细胞株c-Ha-ras基因上游区2.5kb片段的克隆和分析[J].科学通报,1989,34(21):1665-1667.
-
3蔡瑜娇,杨桦,李鹏,刘玲.p27基因启动子甲基化在乳腺癌中的研究[J].重庆医学,2009,38(2):136-138. 被引量：2
-
4朝乐孟,李全福.胆囊癌组织甲基化水平的研究[J].内蒙古医科大学学报,2013,35(2):88-92. 被引量：2
-
5冷历歌,张伟,江涛.DNA甲基化与胶质瘤[J].中国微侵袭神经外科杂志,2009,14(4):190-192. 被引量：1
-
6原继荣,李佩玲,刘丽荣,李璞.妇科恶性肿瘤P16基因甲基化研究[J].中国现代医学杂志,2005,15(3):366-368. 被引量：1
-
7眭鸿颖,史彩霞,夏易曼娜,胡彬.宫颈癌细胞整体甲基化水平与放射敏感性的相关性分析[J].中国妇幼保健,2015,30(30):5106-5108.
-
8汤琪云,姚登福,刘艳华.DNA甲基化水平与肝癌发生关系的研究进展[J].胃肠病学和肝病学杂志,1999,8(3):166-169. 被引量：1
-
9李枫,温碧隆,程志祥,蒋晓平,陈天宾,牟君成.喉鳞状细胞癌中K-ras基因的低甲基化及其蛋白表达[J].中华实验外科杂志,2014,31(10):2302-2304.
-
10罗君,凌志强.DNA甲基化与胃癌的相关性[J].国际肿瘤学杂志,2012,39(2):137-139.
